HER2-Low expression in primary male breast cancer

被引：0
|
作者：
Rudlowski, Christian [1 ]
Erices-Leclercq, Melanie [1 ]
Nobbe, Katleen [1 ]
Baldus, Stephan [2 ]
Foerster, Robert [3 ]
Foerster, Frank [4 ]
Lubig, Sabine [1 ]
机构：
[1] EVK, Bergisch Gladbach, Germany
[2] Inst Pathol & Zytopathol, Bergisch Gladbach, Germany
[3] Cantonal Hosp Winterthur, Inst Radiat Oncol, Winterthur, Switzerland
[4] Poliklinik GmbH, MVZ Gynakol Onkol & Palliat Med, Chemnitz, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
96
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [21] A gene expression-based classifier for HER2-low breast cancer
    Serena Di Cosimo
    Sara Pizzamiglio
    Chiara Maura Ciniselli
    Valeria Duroni
    Vera Cappelletti
    Loris De Cecco
    Cinzia De Marco
    Marco Silvestri
    Maria Carmen De Santis
    Andrea Vingiani
    Biagio Paolini
    Rosaria Orlandi
    Marilena Valeria Iorio
    Giancarlo Pruneri
    Paolo Verderio
    Scientific Reports, 14
  • [22] A gene expression-based classifier for HER2-low breast cancer
    Di Cosimo, Serena
    Pizzamiglio, Sara
    Ciniselli, Chiara Maura
    Duroni, Valeria
    Cappelletti, Vera
    De Cecco, Loris
    De Marco, Cinzia
    Silvestri, Marco
    De Santis, Maria Carmen
    Vingiani, Andrea
    Paolini, Biagio
    Orlandi, Rosaria
    Iorio, Marilena Valeria
    Pruneri, Giancarlo
    Verderio, Paolo
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [23] Clinical, pathological and gene expression features of HER2-low breast cancer
    Schettini, F.
    Chic, N.
    Braso-Maristany, F.
    Pare, L.
    Pascual, T.
    Conte, B.
    Martinez-Saez, O.
    Adamo, B.
    Vidal, M.
    Fernandez-Martinez, A.
    Gonzalez-Farre, B.
    Sanfeliu, E.
    Perrone, G.
    Villagrasa, P.
    Gavila Gregori, J.
    Barrios, C. H.
    Lluch, A.
    Martin Jimenez, M.
    De Placido, S.
    Prat, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S24 - S24
  • [24] Biology and Treatment of HER2-Low Breast Cancer
    Nicolo, Eleonora
    Tarantino, Paolo
    Curigliano, Giuseppe
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (01) : 117 - 132
  • [25] Clinical Significance of HER2-low Breast Cancer
    Zaiem, Fadi
    AbuJamea, Asem
    Kheil, Mira
    Numi, Anna
    Abbas, Omar
    Awada, Sanaa
    Almsaddi, Ragad
    Al-Juburi, Saleh
    Larson, Lauren
    Jain, Deepti
    AlSaghir, Maya
    Jang, Hyejeong
    Kim, Seongho
    Bandyopadhyay, Sudeshna
    Jaiman, Sunil
    Ali-Fehmi, Rouba
    CANCER RESEARCH, 2024, 84 (09)
  • [26] HER2-Low Breast Cancer: a New Subtype?
    Chiara Corti
    Federica Giugliano
    Eleonora Nicolò
    Paolo Tarantino
    Carmen Criscitiello
    Giuseppe Curigliano
    Current Treatment Options in Oncology, 2023, 24 : 468 - 478
  • [27] HER2-low breast cancer: where are we?
    Molinelli, Chiara
    Jacobs, Flavia
    Marchio, Caterina
    Pitto, Francesca
    Cosso, Maurizio
    Spinaci, Stefano
    de Azambuja, Evandro
    Schettini, Francesco
    Agostinetto, Elisa
    Lambertini, Matteo
    BREAST CARE, 2022, 17 (06) : 533 - 544
  • [28] Epidemiology of HER2-low breast cancer in Lithuania
    Cesas, A.
    Poskiene, L.
    Valkiuniene, R. B.
    Radvinskiene, L.
    Lege, I.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 103 - 104
  • [29] HER2-Low Breast Cancer: a New Subtype?
    Corti, Chiara
    Giugliano, Federica
    Nicolo, Eleonora
    Tarantino, Paolo
    Criscitiello, Carmen
    Curigliano, Giuseppe
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (05) : 468 - 478
  • [30] HER2-Low Breast Cancer: Now and in the Future
    Kang, Sora
    Kim, Sung-Bae
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03): : 700 - 720
12345